ABSTRACT
Osteoclasts are multinucleated hematopoietic cells essential for bone resorption. Macrophage colony-stimulating factor (M-CSF) is critical for osteoclast development and function, although its nuclear targets in osteoclasts are largely unknown. Mitf and TFE3 are two closely related helix-loop-helix (HLH) transcription factors previously implicated in osteoclast development and function. We demonstrate that cultured Mitf(mi/mi) osteoclasts are immature, mononuclear, express low levels of TRAP, and fail to mature upon M-CSF stimulation. In addition, M-CSF induces phosphorylation of Mitf and TFE3 via a conserved MAPK consensus site, thereby triggering their recruitment of the coactivator p300. Furthermore, an unphosphorylatable mutant at the MAPK consensus serine is specifically deficient in formation of multinucleated osteoclasts, mimicking the defect in Mitf(mi/mi) mice. These results identify a signaling pathway that appears to coordinate cytokine signaling with the expression of genes vital to osteoclast development.
Subject(s)
DNA-Binding Proteins/metabolism , MAP Kinase Signaling System/physiology , Macrophage Colony-Stimulating Factor/pharmacology , Osteoclasts/physiology , Transcription Factors/metabolism , Amino Acid Motifs , Animals , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors , Cell Differentiation/physiology , Cells, Cultured , DNA-Binding Proteins/genetics , Green Fluorescent Proteins , Humans , Immunohistochemistry , Indicators and Reagents/metabolism , Luminescent Proteins/metabolism , Macrophage Colony-Stimulating Factor/metabolism , Macrophages/cytology , Macrophages/drug effects , Macrophages/metabolism , Mice , Mice, Inbred Strains , Microphthalmia-Associated Transcription Factor , Mitogen-Activated Protein Kinases/metabolism , Osteoclasts/cytology , Osteoclasts/drug effects , Osteopetrosis/physiopathology , PhosphorylationABSTRACT
Microphthalmia (Mi) is a bHLHZip transcription factor that is essential for melanocyte development and postnatal function. It is thought to regulate both differentiated features of melanocytes such as pigmentation as well as proliferation/survival, based on phenotypes of mutant mouse alleles. Mi activity is controlled by at least two signaling pathways. Melanocyte-stimulating hormone (MSH) promotes transcription of the Mi gene through cAMP elevation, resulting in sustained Mi up-regulation over many hours. c-Kit signaling up-regulates Mi function through MAP kinase phosphorylation of Mi, thereby recruiting the p300 transcriptional coactivator. The current study reveals that c-Kit signaling triggers two phosphorylation events on Mi, which up-regulate transactivation potential yet simultaneously target Mi for ubiquitin-dependent proteolysis. The specific activation/degradation signals derive from MAPK/ERK targeting of serine 73, whereas serine 409 serves as a substrate for p90 Rsk-1. An unphosphorylatable double mutant at these two residues is at once profoundly stable and transcriptionally inert. These c-Kit-induced phosphorylations couple transactivation to proteasome-mediated degradation. c-Kit signaling thus triggers short-lived Mi activation and net Mi degradation, in contrast to the profoundly increased Mi expression after MSH signaling, potentially explaining the functional diversity of this transcription factor in regulating proliferation, survival, and differentiation in melanocytes.
Subject(s)
DNA-Binding Proteins/metabolism , Melanocytes/metabolism , Proto-Oncogene Proteins c-kit/metabolism , Ribosomal Protein S6 Kinases, 90-kDa , Transcription Factors , Animals , Blotting, Western , Cells, Cultured , Cricetinae , Cysteine Endopeptidases/metabolism , Humans , Mice , Microphthalmia-Associated Transcription Factor , Mitogen-Activated Protein Kinases/genetics , Mitogen-Activated Protein Kinases/metabolism , Multienzyme Complexes/metabolism , Mutation , Phosphorylation , Proteasome Endopeptidase Complex , Stem Cell Factor/metabolism , Transcriptional Activation , Ubiquitins/metabolismABSTRACT
Melanocyte differentiation characterized by an increased melanogenesis, is stimulated by alpha-melanocyte-stimulating hormone through activation of the cAMP pathway. During this process, the expression of tyrosinase, the enzyme that controls melanin synthesis is upregulated. We previously showed that cAMP regulates transcription of the tyrosinase gene through a CATGTG motif that binds microphthalmia a transcription factor involved in melanocyte survival. Further, microphthalmia stimulates the transcriptional activity of the tyrosinase promoter and cAMP increases the binding of microphthalmia to the CATGTG motif. These observations led us to hypothesize that microphthalmia mediates the effect of cAMP on the expression of tyrosinase. The present study was designed to elucidate the mechanism by which cAMP regulates microphthalmia function and to prove our former hypothesis, suggesting that microphthalmia is a key component in cAMP-induced melanogenesis. First, we showed that cAMP upregulates the transcription of microphthalmia gene through a classical cAMP response element that is functional only in melanocytes. Then, using a dominant-negative mutant of microphthalmia, we demonstrated that microphthalmia is required for the cAMP effect on tyrosinase promoter. These findings disclose the mechanism by which cAMP stimulates tyrosinase expression and melanogenesis and emphasize the critical role of microphthalmia as signal transducer in cAMP-induced melanogenesis and pigment cell differentiation.
Subject(s)
Cyclic AMP/physiology , DNA-Binding Proteins/physiology , Melanocytes/cytology , Signal Transduction , Transcription Factors , 3T3 Cells , Animals , Cell Differentiation/drug effects , DNA-Binding Proteins/genetics , Enzyme Activation , Gene Expression Regulation , Genes, Regulator , Humans , Melanoma, Experimental , Mice , Microphthalmia-Associated Transcription Factor , Monophenol Monooxygenase/genetics , Promoter Regions, Genetic/drug effects , Transcription, Genetic/drug effects , Tumor Cells, CulturedABSTRACT
During melanocyte development, the cytokine Steel factor activates its receptor c-Kit, initiating a signal transduction cascade, which is vital for lineage determination via unknown downstream nuclear targets. c-Kit has recently been found to trigger mitogen-activated protein kinase-mediated phosphorylation of Microphthalmia (Mi), a lineage-restricted transcription factor, which, like Steel factor and c-Kit, is essential for melanocyte development. This cascade results in increased Mi-dependent transcriptional reporter activity. Here we examine the mechanism by which Mi is activated by this pathway. Phosphorylation does not significantly alter Mi's nuclear localization, DNA binding, or dimerization. However, the transcriptional coactivator p300/CBP selectively associates with mitogen-activated protein kinase-phosphorylated Mi, even under conditions in which non-MAPK phospho-Mi is more abundant. Moreover, p300/CBP coactivates Mi transcriptional activity in a manner dependent upon this phosphorylation. Mi thus joins CREB as a transcription factor whose signal-responsive phosphorylation regulates coactivator recruitment, in this case modulating lineage development in melanocytes.
Subject(s)
DNA-Binding Proteins/physiology , Melanocytes/physiology , Nuclear Proteins/physiology , Signal Transduction , Trans-Activators/physiology , Transcription Factors/physiology , Animals , CREB-Binding Protein , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , Cricetinae , DNA-Binding Proteins/genetics , Dimerization , E1A-Associated p300 Protein , Enzyme Activation , Humans , Mice , Microphthalmia-Associated Transcription Factor , Phosphorylation , Protein Binding , Proto-Oncogene Proteins c-kit/physiology , Rabbits , Stem Cell Factor/physiology , Transcriptional Activation , Tumor Cells, CulturedABSTRACT
In mouse follicular melanocytes, production of eumelanins (brown-black pigments) and pheomelanins (yellow-brownish pigments) is under the control of two intercellular signaling molecules that exert opposite actions, alpha-melanocyte-stimulating hormone (alphaMSH) which preferentially increases the synthesis of eumelanins, and agouti signal protein (ASP) whose expression favors the production of hair containing pheomelanins. In this study, we report that ASP does not only affect mature melanocytes but can also inhibit the differentiation of melanoblasts. We show that both alphaMSH and forskolin promote the differentiation of murine melanoblasts into mature melanocytes and that ASP inhibits this process. We present evidence that the expression of a specific melanogenic transcription factor, microphthalmia, and its binding to an M box regulatory element, is inhibited by ASP. We also show that, in B16 murine melanoma cells, ASP inhibits alphaMSH-stimulated expression of tyrosinase, tyrosine-related proteins 1 and 2 through an inhibition of the transcription activity of their respective promoters. Further, ASP inhibits alphaMSH-induced expression of the microphthalmia gene and reduces the level of microphthalmia in the cells. Our data demonstrate that ASP can regulate both melanoblast differentiation and melanogenesis, pointing out the key role of microphthalmia in the control of these processes.
Subject(s)
Cell Differentiation/drug effects , DNA-Binding Proteins/physiology , Intercellular Signaling Peptides and Proteins , Melanocytes/drug effects , Proteins/pharmacology , Transcription Factors , Agouti Signaling Protein , Animals , Colforsin/pharmacology , Cyclic AMP/pharmacology , Fungal Proteins/genetics , Gene Expression Regulation/drug effects , Melanins/biosynthesis , Melanoma/metabolism , Membrane Proteins/genetics , Mice , Microphthalmia-Associated Transcription Factor , Monophenol Monooxygenase/genetics , TRPC Cation Channels , Tumor Cells, Cultured , alpha-MSH/pharmacologyABSTRACT
Microphthalmia (Mi) is a basic helix-loop-helix-leucine zipper (b-HLH-ZIP) transcription factor implicated in pigmentation, mast cells, and bone development. Two dominant-negative mi alleles (mi/mi and Mior/Mior) in mice cause osteopetrosis. In contrast, osteopetrosis has not been observed in a number of recessive mi alleles, suggesting the existence of Mi protein partners important in osteoclast function. An osteopetrotic rat of unknown genetic defect (mib) has been described whose skeletal sclerosis improves dramatically with age and that is associated with pigmentation defects reminiscent of mouse mi alleles. Here we report that this rat strain harbors a large genomic deletion encompassing the 3' half of mi including most of the b-HLH-ZIP region. Osteoclasts from these animals lack Mi protein in contrast to wild-type rat, mouse, and human osteoclasts. Mi is not detectable in primary osteoblasts. In addition TFE3, a b-HLH-ZIP transcription factor related to Mi, was found to be expressed in osteoclasts, but not osteoblasts, and to coimmunoprecipitate with Mi. These results demonstrate the existence of members of a family of biochemically related transcription factors that may cooperate to play a central role in osteoclast function and possibly in age-related osteoclast homeostasis.
Subject(s)
DNA-Binding Proteins/genetics , DNA-Binding Proteins/physiology , Microphthalmos/genetics , Osteoclasts/physiology , Osteopetrosis/etiology , Transcription Factors/physiology , Animals , Base Sequence , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors , Gene Expression , Helix-Loop-Helix Motifs , Humans , Leucine Zippers , Mice , Microphthalmia-Associated Transcription Factor , Molecular Sequence Data , Osteoblasts/metabolism , RNA, Messenger/genetics , Rats , Rats, Mutant Strains , Sequence Alignment , Sequence Homology, Nucleic AcidABSTRACT
Germline mutations at loci encoding the transcription factor Microphthalmia (Mi), the cytokine receptor c-Kit, or its ligand Steel factor (S1) result in strikingly similar defects in mast cell and melanocyte development. Here we describe a biochemical link between Kit signalling and the activity of Mi. Stimulation of melanoma cells with S1 results in activation of MAP kinase, which in turn phosphorylates Mi at a consensus target serine. This phosphorylation upregulates Mi transactivation of the tyrosinase pigmentation gene promoter. In addition to modulating pigment production, such signalling may regulate the expression of genes essential for melanocyte survival and development. The pathway represents a new application of the general MAP kinase machinery in transducing a signal between a tissue-specific receptor at the cell surface and a tissue-specific transcription factor in the nucleus.
Subject(s)
DNA-Binding Proteins/metabolism , MAP Kinase Kinase Kinase 1 , Melanocytes/metabolism , Proto-Oncogene Proteins c-kit/metabolism , Signal Transduction , Transcription Factors , Calcium-Calmodulin-Dependent Protein Kinases/antagonists & inhibitors , Calcium-Calmodulin-Dependent Protein Kinases/metabolism , DNA-Binding Proteins/genetics , Enzyme Inhibitors/pharmacology , Flavonoids/pharmacology , Humans , Microphthalmia-Associated Transcription Factor , Mutagenesis, Site-Directed , Phosphorylation , Protein Serine-Threonine Kinases/antagonists & inhibitors , Serine/metabolism , Tumor Cells, CulturedABSTRACT
The microphthalmia (mi) gene appears essential for pigment cell development and/or survival, based on its mutation in mi mice. It has also been linked to the human disorder Waardenburg Syndrome. The mi gene was recently cloned and predicts a basic/helix-loop-helix/leucine zipper (b-HLH-ZIP) factor with tissue-restricted expression. Here, we show that Mi protein binds DNA as a homo- or heterodimer with TFEB, TFE3, or TFEC, together constituting a new MiT family. Mi can also activate transcription through recognition of the M box, a highly conserved pigmentation gene promoter element, and may thereby determine tissue-specific expression of pigmentation enzymes. Six mi mutations shown recently to cluster in the b-HLH-ZIP region produce surprising and instructive effects on DNA recognition and oligomerization. An alternatively spliced exon located outside of the b-HLH-ZIP region is shown to significantly modulate DNA recognition by the basic domain. These findings suggest that Mi's critical roles in melanocyte survival and pigmentation are mediated by MiT family interactions and transcriptional activities.
Subject(s)
DNA-Binding Proteins/pharmacology , Melanocytes/physiology , Transcription Factors , Alternative Splicing , Animals , Base Sequence , Gene Expression Regulation , Genes, Reporter , Mice , Microphthalmia-Associated Transcription Factor , Molecular Sequence Data , MutationABSTRACT
Tenascin (TN) is an extracellular matrix protein that is expressed widely in the fetus and sparingly in the adult, but reappears at high levels in certain areas of tissue insult such as tumor matrices and sites of wound healing. We show here that soluble TN inhibits proliferation of human T cells in response to alpha CD3 Ab co-immobilized with the extracellular matrix protein fibronectin (FN). TN also inhibits proliferation driven by alpha CD3/IL-2 or by phorbol ester/IL-2, and it prevents high level induction of IL-2R. The presence of TN in culture medium does not detectably alter the pattern of tyrosine phosphorylation resulting from T cell triggering with alpha CD3, but at later time points prevents the appearance of functional NF-AT1 transcription factor complexes in T cell nuclear extracts. These findings are consistent with the postulated role for TN as a natural antagonist to FN action, and suggest that T cell responses occurring at tissue sites in which TN is expressed could be influenced by its presence.
Subject(s)
Cell Adhesion Molecules, Neuronal/pharmacology , Extracellular Matrix Proteins/pharmacology , Lymphocyte Activation/drug effects , Nuclear Proteins , T-Lymphocytes/drug effects , Base Sequence , Cells, Cultured , DNA-Binding Proteins/metabolism , Humans , Interleukin-2/metabolism , Molecular Sequence Data , NFATC Transcription Factors , Phosphorylation , Receptors, Interleukin-2/analysis , Receptors, Very Late Antigen/physiology , Tenascin , Transcription Factors/metabolism , Tyrosine/metabolismABSTRACT
Tenascin (TN) is an extracellular matrix glycoprotein that is widely expressed in fetal tissues and tumor matrices but is absent from most normal adult tissues. It is transiently expressed at sites of wound healing and has been shown to inhibit some types of T cell activation. We have examined the expression of TN in rat and human thymic tissue. Our results indicate that TN is expressed in both neonatal and adult rat thymus, and that in human thymus TN is present in a meshlike network at the corticomedullary junction. In addition, cultured human thymic non-lymphoid cells grown in serum-containing medium synthesize TN, whereas under serum-free conditions these cells secrete TN in response to transforming growth factor-beta.
Subject(s)
Cell Adhesion Molecules, Neuronal/metabolism , Extracellular Matrix Proteins/metabolism , Thymus Gland/metabolism , Age Factors , Animals , Animals, Newborn , Child, Preschool , Humans , Immunohistochemistry , Infant , Infant, Newborn , Rats , Tenascin , Thymus Gland/cytologyABSTRACT
Hexabrachion (Tenascin) is a large glycoprotein that appears in extracellular matrices as a disulfide-linked multimer. It is synthesized in an ordered fashion at particular sites during development, is made in large amounts by certain tumors, and is found in restricted tissue locations in the adult. In this report, we describe the sequence of a full length cDNA of human hexabrachion. The encoded protein contains a total of 2203 amino acids and is a linear array of discrete reiterated domains. At the 5' end are encoded hydrophobic residues and 8 flanking cysteines predicted to be responsible for assembly of hexabrachion polypeptides into a radially arranged, six-armed complex. Following this region are 14 1/2 contiguous 31-amino acid epidermal growth factor-like repeats that have a unique structure with respect to the known examples of this type of domain. Immediately adjacent to these repeats lie 15 uninterrupted segments of approximately 90 amino acids which are similar to the Type III units found in fibronectin. At the carboxyl terminus of the protein is a 210-amino acid domain that is similar to fibrinogen. The domain structure of this protein is consistent with the potential for interaction with multiple ligands and for roles in cell adhesion and/or signaling.
Subject(s)
Cell Adhesion Molecules, Neuronal/genetics , DNA/genetics , Epidermal Growth Factor/genetics , Extracellular Matrix Proteins/genetics , Extracellular Matrix/metabolism , Repetitive Sequences, Nucleic Acid , Amino Acid Sequence , Cell Adhesion , Humans , Molecular Sequence Data , Protein Conformation , Restriction Mapping , TenascinABSTRACT
The binding of nominal antigen to Ti alpha-beta heterodimers on MHC-restricted human T cell clones specific for fluorescein-5-isothiocyanate (FL) was detected by flow cytometry and affinity chromatography. The FL-Ti interaction is of physiologic significance, since T cell activation is induced by cross-linked arrays of FL in the absence of the specific MHC recognition. High antigen valence is required to achieve stable binding to cells and subsequent activation, which is consistent with estimated Ti-FL association constants of less than 3 X 10(5) l/mol. In addition to providing direct evidence that the Ti alpha-beta heterodimer is the receptor for antigen, these data suggest that nominal antigen binding sites exist on the Ti molecules of at least some MHC-restricted clones.